Exploring pharmacogenetic testing for DPD deficiency – FDA Oncology – OncoDaily
Exploring pharmacogenetic testing for DPD deficiency – FDA Oncology / AACR, cancer, DPD deficiency, FDA Oncology, Jennifer Gao, OncoDaily, Oncology, Patricia
Related Articles
How a Never-Wavering Enthusiasm Changed Lung Cancer Care for the Better
As a female leader in a competitive oncology field, Solange Peters, MD, PhD, pushed through the barriers— climbed over them—and completely transformed lung cancer care…
Deimplementation Strategy to Reduce Low-Value Preoperative Testing
This quality improvement study investigates if a multicomponent deimplementation strategy directed at clinicians is associated with a reduction in low-value testing before general surgery operations.
Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident cancer burden attributable to PFAS in drinking water in the United States
Journal of Exposure Science & Environmental Epidemiology – Associations between per-and polyfluoroalkyl substances (PFAS) and county-level cancer incidence between 2016 and 2021 and incident…
Biden proposes front-of-pack food labels in his final days in office
The Biden administration’s proposal is a last-ditch effort to put its stamp on the nation’s food policy before President-elect Donald Trump takes office.
CD137 agonism enhances anti-PD1 induced activation of expanded CD8+ T cell clones in a neoadjuvant pancreatic cancer clinical trial
Health sciences; Medicine; Medical specialty; Internal medicine; Oncology
Use of Digital Health Technologies by Older US Adults
This survey study estimated digital health technology (DHT) use and evaluated the factors associated with DHT use by US adults aged 50 to 80 years.
Pancreatic cancer-derived extracellular vesicles remodel the tumor microenvironment and enhance chemoresistance by delivering KRASG12D protein to cancer-associated fibroblasts
Prof. Bai and colleagues discovered that extracellular vesicles derived from pancreatic cancer cells reprogram the tumor microenvironment and augment chemotherapy resistance by transferring the KRASG12D…
OncoInfluencers to Follow on Social Media: Dr. Komal Jhaveri – OncoDaily
OncoInfluencers to Follow on Social Media: Dr. Komal Jhaveri / Breast Cancer, cancer, Komal Jhaveri, LinkedIn, Memorial Sloan Kettering Cancer Center,
Methods to Explain the Clinical Significance of Health Status Measures
One can classify ways to establish the interpretability of quality-of-life measures as anchor based or distribution based. Anchor-based measures require an independent standard or anchor…